Literature DB >> 10385414

Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase.

I J Bujalska1, S Kumar, M Hewison, P M Stewart.   

Abstract

Glucocorticoids play an important role in determining adipose tissue distribution and function, with glucocorticoid excess states such as Cushing's syndrome resulting in central obesity. We have investigated the functional significance of local generation of cortisol within adipose tissue from inactive cortisone through the activity of the NADP(H)-dependent enzyme, 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1). In primary cultures of paired omental (om) and sc human adipose stromal cells (ASC; n = 34), 11betaHSD1 oxo-reductase activity was significantly higher in om ASC (median, 40.2 pmol/mg protein x h; 95% confidence interval, 1.8-105) compared with sc ASC (median, 11.4; 95% confidence interval, 0-48.1; P<0.001) despite similar endogenous NADPH/NADP concentrations. Both cortisol and insulin increased the differentiation of ASC to adipocytes (as assessed by glycerol-3-phosphate dehydrogenase expression), but only cortisol increased 11betaHSD1 activity and messenger RNA levels in a dose-dependent fashion. Cortisone (500 nM) was as effective as 500 nM cortisol in inducing ASC differentiation, but this stimulatory effect was inhibited by coincubation with the 11betaHSD1 inhibitor, glycyrrhetinic acid. The higher local conversion of cortisone to active cortisol through expression of 11betaHSD1 in om compared with sc ASC may explain the specific action of glucocorticoids on different adipose tissue depots. 11betaHSD1 expression in om ASC is regulated at a transcriptional level and is increased by glucocorticoids, but is not entirely dependent upon ASC differentiation. Inhibition of 11betaHSD1 within om ASC inhibits cortisone-induced ASC differentiation. These findings indicate that local metabolism of glucocorticoid may control differentiation of adipose tissue in a site-specific fashion. Specific inhibitors of 11betaHSD1 may offer a novel approach for the treatment of patients with central obesity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385414     DOI: 10.1210/endo.140.7.6868

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  52 in total

1.  Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.

Authors:  George Michas; Marcel Liberman; Kristian C Becker; Diane E Handy; Joseph Loscalzo; Jane A Leopold
Journal:  Mol Cell Biochem       Date:  2010-10-05       Impact factor: 3.396

Review 2.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.

Authors:  Deborah J Wake; Brian R Walker
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Effect of licorice on the reduction of body fat mass in healthy subjects.

Authors:  D Armanini; C B De Palo; M J Mattarello; P Spinella; M Zaccaria; A Ermolao; M Palermo; C Fiore; P Sartorato; F Francini-Pesenti; I Karbowiak
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 4.  "Cushing's disease of the omentum"--fact or fiction?

Authors:  J W Tomlinson; P M Stewart
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

Review 5.  Obesogens, stem cells and the developmental programming of obesity.

Authors:  A Janesick; B Blumberg
Journal:  Int J Androl       Date:  2012-02-28

Review 6.  Tissue-specific dysregulation of 11beta-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome.

Authors:  P Putignano; F Pecori Giraldi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 7.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

8.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

Review 9.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

10.  Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue.

Authors:  Mi-Jeong Lee; Susan K Fried; Steven S Mundt; Yanxin Wang; Sean Sullivan; Alice Stefanni; Bruce L Daugherty; Anne Hermanowski-Vosatka
Journal:  Obesity (Silver Spring)       Date:  2008-04-03       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.